Status:
COMPLETED
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Lead Sponsor:
UCB Pharma SA
Conditions:
Narcolepsy With Cataplexy
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
To monitor for endocrine changes in response to treatment of cataplexy with Xyrem, to focus on the hypothalamic pituitary axis and to confirm the safety of Xyrem on potential endocrine changes.
Eligibility Criteria
Inclusion
- Narcoleptic patients with cataplexy
Exclusion
- Subjects not diagnosed with narcolepsy with cataplexy
Key Trial Info
Start Date :
April 10 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2008
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00345800
Start Date
April 10 2006
End Date
January 22 2008
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liège, Belgium